CCR5 RNA transcription based amplification assay
US6204024A · kind A · utility
0Cited by
15References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 1997 |
| Grant date | Mar 20, 2001 |
| Priority date | — |
| Expiry date | Sep 12, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/703
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method and a test kit for genotyping the CCR5 chemokine receptor. CCR5 transcript DNA is amplified using transcription based amplification. The amplification product is detected through the hybridization of appropriately labeled oligonucleotide wild type and mutant probes. In a liquid hybridization based ECL analysis, the mutant probe is a 16mer having the sequence 5'TCCATACATTAAAGAT3' [SEQ ID NO:9]. The method and kit can be used to predict.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.